Status:
RECRUITING
Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions:
Artificial Intelligence
Deep Learning
Eligibility:
All Genders
18-75 years
Brief Summary
To improve the accuracy of risk prediction, screening and treatment outcome of cancer, we aim to establish a medical database that includes standardized and structured clinical diagnosis and treatment...
Detailed Description
The main aims are as follows: 1. To establish a data platform for multi-modal information of common tumors (lung cancer/pulmonary nodules, stomach and colorectal cancers) : electronic medical records...
Eligibility Criteria
Inclusion
- Participants with the suspected of lung cancer/node, or stomach cancer/lesion, or colorectal cancer/leision
- Participants that have signed informed consent.
- Participants with detailed electronic medical records, image records, pathological records, multi-omics information, and other important clinical diagnostic information.
- Healthy participants with no clinical diagnosis of lung cancer/node, or stomach cancer/lesion, or colorectal cancer/leision.
Exclusion
- Participants with primary clinical and pathological data missing.
- Participants lost to follow-up.
- Participants with too poor medical image quality to perform segment and mark ROI accurately
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT05426135
Start Date
June 1 2022
End Date
October 1 2026
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430000